Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2026-05-10 @ 7:12 PM
Study NCT ID:
NCT03175367
Status:
COMPLETED
Last Update Posted:
2023-02-10
First Post:
2017-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Sponsor:
Regeneron Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R1500-CL-1643
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None